Abstract
Spermatogenesis involves action and interaction of several genes present both on the autosome and sex chromosomes. Protooncogene c-kit receptor is one such autosomal gene implicated with hematopoiesis, melanogenesis and spermatogenesis. A sizable body of literature is available on the regulatory role of this gene, its ligand “stem cell factor” and its functional conservation across the species. Sequences from the extracellular domains of c-kit cDNA show organizational uniqueness across the species conferring species specificity. Studies on fertile and infertile Brown Norway rats enabled identification of mutant mRNA transcript in the testis of infertile animals. These animals showed heavily regressed seminiferous tubules. No such mutant mRNA transcript was detected in the somatic tissues of infertile or normal animals. The mutant mRNA transcript was found in accordance with the regressed seminiferous tubules observed in the testicular histological section of the infertile rats. A perusal of literature and our own study suggest that alternate splicing of c-kit gene gives rise to multiple mRNA transcripts of which at least one is involved in control and regulation of fertility in conjunction with its ligand “stem cell factor” and perhaps other autosomal genes. In this article, we present a brief overview on the organization and expression of protooncogene c-kit receptor and its mutational status in Brown Norway rats (Rattus norvegicus). It is envisaged that information emerging from animal systems will facilitate the overall understanding of the phenomenon of fertility in the human as well.
Keywords: spermatogenesis, pleiotropism, rt-pcr, differential expression, extracellular domain, seminomas
Current Pharmacogenomics
Title: Biology of Protooncogene c-kit Receptor and Spermatogenesis
Volume: 2 Issue: 1
Author(s): Supriya Gangadharan Prasanth, Harleen Mangat Giran and Sher Ali
Affiliation:
Keywords: spermatogenesis, pleiotropism, rt-pcr, differential expression, extracellular domain, seminomas
Abstract: Spermatogenesis involves action and interaction of several genes present both on the autosome and sex chromosomes. Protooncogene c-kit receptor is one such autosomal gene implicated with hematopoiesis, melanogenesis and spermatogenesis. A sizable body of literature is available on the regulatory role of this gene, its ligand “stem cell factor” and its functional conservation across the species. Sequences from the extracellular domains of c-kit cDNA show organizational uniqueness across the species conferring species specificity. Studies on fertile and infertile Brown Norway rats enabled identification of mutant mRNA transcript in the testis of infertile animals. These animals showed heavily regressed seminiferous tubules. No such mutant mRNA transcript was detected in the somatic tissues of infertile or normal animals. The mutant mRNA transcript was found in accordance with the regressed seminiferous tubules observed in the testicular histological section of the infertile rats. A perusal of literature and our own study suggest that alternate splicing of c-kit gene gives rise to multiple mRNA transcripts of which at least one is involved in control and regulation of fertility in conjunction with its ligand “stem cell factor” and perhaps other autosomal genes. In this article, we present a brief overview on the organization and expression of protooncogene c-kit receptor and its mutational status in Brown Norway rats (Rattus norvegicus). It is envisaged that information emerging from animal systems will facilitate the overall understanding of the phenomenon of fertility in the human as well.
Export Options
About this article
Cite this article as:
Prasanth Gangadharan Supriya, Giran Mangat Harleen and Ali Sher, Biology of Protooncogene c-kit Receptor and Spermatogenesis, Current Pharmacogenomics 2004; 2 (1) . https://dx.doi.org/10.2174/1570160043476114
DOI https://dx.doi.org/10.2174/1570160043476114 |
Print ISSN 1570-1603 |
Publisher Name Bentham Science Publisher |
Online ISSN 1570-1603 |
Related Articles
-
Innovations and Opportunities to Improve Conventional (Deoxy)Nucleoside and Fluoropyrimidine Analogs in Cancer
Current Medicinal Chemistry Developments of Combretastatin A-4 Derivatives as Anticancer Agents
Current Medicinal Chemistry Epidemiology and Management of Infectious Complications in Contemporary Management of Chronic Leukemias
Infectious Disorders - Drug Targets CDK Inhibitors: From the Bench to Clinical Trials
Current Drug Targets pH-Sensitive PEGylated Liposomes Functionalized With a Fibronectin-Mimetic Peptide Show Enhanced Intracellular Delivery to Colon Cancer Cells
Current Pharmaceutical Biotechnology Direct Targeting of the Ras GTPase Superfamily Through Structure- Based Design
Current Topics in Medicinal Chemistry The Role of Tregs in Cancer: Foxp3 as a Putative Target for Therapy
Current Signal Transduction Therapy Bhasma: Indian Perspective of Nanomedicinal Technology
Recent Patents on Nanomedicine Ras Dimer Formation as a New Signaling Mechanism and Potential Cancer Therapeutic Target
Mini-Reviews in Medicinal Chemistry 5q- syndrome
Current Pharmaceutical Design Current Understanding of Dietary Polyphenols and their Role in Health and Disease
Current Nutrition & Food Science Synthesis and Studies of Anticancer and Antimicrobial Activity of New Phenylurenyl Chalcone Derivatives
Letters in Drug Design & Discovery Heat Shock Protein 90 Inhibitors in Oncology
Current Proteomics Energy Dependent Transport of Xenobiotics and Its Relevance to Multidrug Resistance
Current Cancer Drug Targets Genetics and Genomics Interventions for Promoting Millets as Functional Foods
Current Genomics Molecules of Parasites as Immunomodulatory Drugs
Current Topics in Medicinal Chemistry Differential Role of Apoptosis and Autophagy Associated with Anticancer Effect of Lupulone (Hop β-Acid) Derivatives on Prostate Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry DNA Drug Design for Cancer Therapy
Current Pharmaceutical Design Mesenchymal Stromal Cells Uptake and Release Paclitaxel without Reducing its Anticancer Activity
Anti-Cancer Agents in Medicinal Chemistry Eph/Ephrin Membrane Proteins: A Mammalian Expression Vector pTIg- BOS-Fc Allowing Rapid Protein Purification
Protein & Peptide Letters